Could a weekly injection replace daily drugs for Parkinson's patients?
After more than two years of research, scientists have developed a long-lasting weekly injection, offering hope to patients who currently face the exhausting task of taking several pills multiple times a day.
According to the Parkinson's Foundation, the disease affects more than 10 million people globally, with men 1.5 times more likely to be diagnosed than women. It is the second-most common neurodegenerative disease after Alzheimer's.
For those living with Parkinson's, the standard treatment involves daily doses of medications that must be taken precisely on schedule.
'Especially concerning elderly patients, they have to remember each medication timely, and take the medication," said University of South Australia researcher Deepa Nakmode.
"Even if they miss a single dose, they can't perform day-to-day activities normally".
And missing doses is alarmingly common.
'Almost 50 per cent of patients don't take medicines as recommended by doctors, especially in chronic conditions,' said Sanjay Garg, a pharmaceutical science professor at the University of South Australia.
'It's going to be a game-changer'
The new injection combines two key drugs (Levodopa and Carbidopa) into one injectable dose that slowly releases the medication over the course of seven days.
'One injection will be good for one week as compared to a patient taking three or four tablets every day,' Garg said.
These drugs are primarily used to manage Parkinson's symptoms, which commonly include tremour, muscle rigidity, and slowness of movement. Patients can also experience problems with balance, which can raise the risk of falls.
Although the new injection has not yet undergone clinical trials in humans, researchers plan to start animal testing in the coming months.
For people like Peter Willis, who was diagnosed with Parkinson's 10 years ago and currently takes medication four times per day, the breakthrough could be life-changing.
'If you don't take the tablet on time, you discover you can't walk,' he said. 'You sort of lose your energy as if you run out of fuel. You take the tablet again and then it picks up.'
Parkinson's Australia has hailed the development as a major breakthrough, especially given the slow pace of progress in treatment innovation in recent years.
'It will reduce falls risks, it will mean that people can actively participate in everyday life like work and sport and volunteering," said Parkinson's Australia CEO Olivia Nassaris.
"It's going to be a game-changer,' she added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Euronews
2 days ago
- Euronews
Could a weekly injection replace daily drugs for Parkinson's patients?
For many living with Parkinson's disease, the daily ritual of taking multiple pills per day can be as daunting task. But a new breakthrough from researchers at the University of South Australia could ease this burden – and potentially change the way Parkinson's is treated forever. After more than two years of research, scientists have developed a long-lasting weekly injection, offering hope to patients who currently face the exhausting task of taking several pills multiple times a day. According to the Parkinson's Foundation, the disease affects more than 10 million people globally, with men 1.5 times more likely to be diagnosed than women. It is the second-most common neurodegenerative disease after Alzheimer's. For those living with Parkinson's, the standard treatment involves daily doses of medications that must be taken precisely on schedule. 'Especially concerning elderly patients, they have to remember each medication timely, and take the medication," said University of South Australia researcher Deepa Nakmode. "Even if they miss a single dose, they can't perform day-to-day activities normally". And missing doses is alarmingly common. 'Almost 50 per cent of patients don't take medicines as recommended by doctors, especially in chronic conditions,' said Sanjay Garg, a pharmaceutical science professor at the University of South Australia. 'It's going to be a game-changer' The new injection combines two key drugs (Levodopa and Carbidopa) into one injectable dose that slowly releases the medication over the course of seven days. 'One injection will be good for one week as compared to a patient taking three or four tablets every day,' Garg said. These drugs are primarily used to manage Parkinson's symptoms, which commonly include tremour, muscle rigidity, and slowness of movement. Patients can also experience problems with balance, which can raise the risk of falls. Although the new injection has not yet undergone clinical trials in humans, researchers plan to start animal testing in the coming months. For people like Peter Willis, who was diagnosed with Parkinson's 10 years ago and currently takes medication four times per day, the breakthrough could be life-changing. 'If you don't take the tablet on time, you discover you can't walk,' he said. 'You sort of lose your energy as if you run out of fuel. You take the tablet again and then it picks up.' Parkinson's Australia has hailed the development as a major breakthrough, especially given the slow pace of progress in treatment innovation in recent years. 'It will reduce falls risks, it will mean that people can actively participate in everyday life like work and sport and volunteering," said Parkinson's Australia CEO Olivia Nassaris. "It's going to be a game-changer,' she added.
Euronews
31-07-2025
- Euronews
Light stimulation shows promise in slowing Parkinson's, scientists say
French scientists are experimenting with a new way to combat Parkinson's disease: using light to stimulate damaged nerve cells in the brain. Researchers from a biomedical research centre affiliated with Grenoble University Hospital announced their progress on Radio France, explaining that while the trial is still at a very early stage, it could lead to breakthroughs in the treatment of the neurodegenerative disease. Around 10 million people worldwide have Parkinson's, and that figure is expected to double by 2050, according to Parkinson's Europe. There is no cure, but researchers have been searching for ways to slow the disease and alleviate symptoms, which include tremours, muscle rigidity, and slowness of movement. If it is successful in larger studies, the French clinical trial could help disrupt the progression of the disease through a non-invasive technique that stimulates the functional recovery of neurons, or nerve cells. The study targets dopamine-secreting neurons, which are critically affected as Parkinson's progresses. Around half of these cells may be damaged by the time symptoms appear, while patients lose an average of 10 per cent of their dopamine receptors per year, according to Dr Stephan Chabardès, a neurosurgeon at Grenoble University Hospital. The aim of the trial is to slow down patients' neurological deterioration, Chabardès said. The technique directs light beams to neurons deep inside the brain to target mitochondria – responsible for energy production within the cell – to stimulate them and improve their function, thereby revitalising the damaged cells. Chabardès said that in order to access these deep brain regions, the researchers developed a special compact device that combines advanced expertise in electronics, photonics, and nanotechnology, enabling the system to get smaller without sacrificing performance. "It is the combination of this medical expertise in neurosurgery with expertise in micro and nanotechnologies that makes it possible to achieve these medical feats," he said. So far, the technology has been applied to seven patients with early stages of the disease, and preliminary results indicate a slowdown in the deterioration of symptoms in three of them, especially with continued stimulation. It appeared that the light stimulation helped restore some brain function in these three cases, Chabardès said. "It's very preliminary, but what we are seeing is quite promising," Chabardès said. He noted that researchers will only launch a larger clinical trial if the study finds a tangible and stable effect.
Euronews
29-07-2025
- Euronews
Want to age well? Get active, challenge your brain, and eat healthy
It's official: Older adults worried about cognitive decline can stay sharper for longer by exercising both their bodies and their brains and eating healthier. That's according to initial results released Monday from a rigorous US study of lifestyle changes in seniors at risk of developing dementia. People following a combination of healthier habits slowed typical age-related cognitive decline — achieving scores on brain tests as if they were a year or two younger, researchers reported in the medical journal JAMA. It's not too late to get started — study participants were in their 60s and 70s — and it doesn't require becoming a pickleball champ or swearing off ice cream. 'It was the first time I felt like I was doing something proactive to protect my brain,' said Phyllis Jones, 66, from the US state of Illinois. She joined the study after caring for her mother with dementia and struggling with her own health problems. It's too soon to know if stalling age-related decline also could reduce the risk of later Alzheimer's or other forms of dementia. But Jones and other study participants underwent brain scans and blood tests that researchers now are analysing for clues — such as whether people also saw a reduction in Alzheimer's-related protein buildup. 'We're all on a cognitive ageing clock and anything we can do to slow that clock down, to me, that is a significant benefit,' said Laura Baker of Wake Forest University School of Medicine, who led the study. Doctors have long encouraged physical activity and a healthy diet for brain fitness. Those steps fight high blood pressure and cholesterol, heart disease, and diabetes, factors that increase the risk of dementia. But until now the strongest evidence that specific lifestyle changes later in life could improve how people perform on brain tests came from a study in Finland. How the study worked Half of participants were randomly assigned to group classes for exercise and dietary changes plus brain-challenging homework — with peer support and coaches tracking their progress. They did a half-hour of moderately intense exercise four times a week — plus twice a week, they added 10 to 15 minutes of stretching and 15 to 20 minutes of resistance training. They followed the 'MIND diet' that stresses lots of leafy greens and berries plus whole grains, poultry, and fish. Nothing is banned, but it urges limiting red meat, fried or fast food, and sweets, and substituting olive oil for butter and margarine. They also had to meet someone or try something new weekly and do brain 'exercises' using an online programme called Brain HQ. Other study participants, the control group, received brain-healthy advice and minimal coaching — they chose what steps to follow. Both improved but the group with more support fared significantly better. Combining social engagement with exercise and dietary steps may be key, said Jessica Langbaum of the Banner Alzheimer's Institute, who wasn't involved with the study. 'Americans want to have that one easy thing — 'If I just eat my blueberries,'' Langbaum said. 'There is no one magic bullet. It is a whole lifestyle". How to exercise your body and mind on your own Moderately intense physical activity means raising your heart rate and panting a bit yet still being able to talk, said Wake Forest's Baker. Pick something safe for your physical capability and start slowly, just 10 minutes at a time until you can handle more, she cautioned. Make it something you enjoy so you stick with it. Likewise there are many options for brain exercise, Baker said — puzzles, joining a book club, learning an instrument or a new language. One challenge: How to keep up the good work Researchers will track study participants' health for four more years, and the Alzheimer's Association is preparing to translate the findings into local community programmes. Will people with stick with their new habits? Jones lost 30 pounds, saw her heart health improve and feels sharper, especially when multitasking. But she hadn't realised her diet slipped when study coaching ended until a checkup spotted rising blood sugar. Now she and an 81-year-old friend from the study are helping keep each other on track. The lifestyle change 'did not just affect me physically, it also affected me mentally and emotionally. It brought me to a much better place,' Jones said.
